Research
Identification of gamma-hydroxybutyrate (GHB)–β-ribose as a promising biomarker enabling prolonged detection of GHB intake
Science · By Kathrine Bohn Faldborg, Jørgen Bo Hasselstrøm, Lambert Kristiansen Sørensen, Camilla Bak Nielsen, Søren Lau Borcher Møller, Thomas B. Poulsen, Mogens Johannsen, Charlotte Uggerhøj Andersen & Kirstine Lykke Nielsen ·
The Brief
- A study published in Science Advances proposes GHB–β-ribose as a biomarker for GHB intake.
- The authors describe it as a promising biomarker that could enable prolonged detection of GHB intake.
- The source material provided contains no further details on methods, sample sizes, or validation.
Why it matters
If validated, a biomarker that remains detectable longer than GHB itself could extend the window in which GHB intake can be confirmed, which matters for toxicology and forensic investigations.
Who’s affected
- toxicologists and forensic scientists
- clinicians and investigators who handle suspected GHB exposure
- #ghb
- #biomarker
- #toxicology
- #forensic-science
- #drug-detection
Science Advances, Volume 12, Issue 46 , November 2026.
Timeline
Study published in Science Advances (Volume 12, Issue 46)
science.org
Identification of gamma-hydroxybutyrate (GHB)–β-ribose as a promising biomarker enabling prolonged detection of GHB intake